Aevis Victoria SA (SWX:AEVS)
Switzerland · Delayed Price · Currency is CHF 15.10
+0.35 (2.37%)
Oct 2, 2026, 5:30 PM CET
Aevis Victoria Market Cap
Aevis Victoria has a market cap or net worth of 1.28 billion as of October 2, 2026. Its market cap has increased by 11.77% in one year.
Market Cap
1.28B
Enterprise Value
2.27B
Revenue
1.05B
Ranking
n/a
PE Ratio
n/a
Stock Price
15.10
ChartMarket Cap Chart
Since July 5, 1999, Aevis Victoria's market cap has increased from 2.40M to 1.28B, an increase of 53,363.26%. That is a compound annual growth rate of 25.91%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 1.28B | 13.86% |
| Dec 30, 2025 | 1.13B | -10.38% |
| Dec 30, 2024 | 1.26B | -11.76% |
| Dec 29, 2023 | 1.42B | -3.64% |
| Dec 30, 2022 | 1.48B | 20.89% |
| Dec 30, 2021 | 1.22B | 17.77% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 279.40B |
| Novartis AG | 228.01B |
| Lonza Group AG | 40.17B |
| Galderma Group AG | 38.67B |
| Medacta Group | 2.28B |
| SKAN Group AG | 1.59B |
| PolyPeptide Group AG | 1.46B |
| Idorsia | 1.25B |